1. Home
  2. DEI vs VIR Comparison

DEI vs VIR Comparison

Compare DEI & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Douglas Emmett Inc.

DEI

Douglas Emmett Inc.

HOLD

Current Price

$12.38

Market Cap

1.8B

Sector

Real Estate

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$8.68

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DEI
VIR
Founded
1971
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
2006
2019

Fundamental Metrics

Financial Performance
Metric
DEI
VIR
Price
$12.38
$8.68
Analyst Decision
Hold
Strong Buy
Analyst Count
8
7
Target Price
$12.94
$19.43
AVG Volume (30 Days)
2.2M
1.9M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
7.06%
N/A
EPS Growth
N/A
17.49
EPS
N/A
N/A
Revenue
$1,003,982,000.00
$68,556,000.00
Revenue This Year
$1.70
$270.22
Revenue Next Year
$2.35
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.77
N/A
52 Week Low
$9.04
$4.16
52 Week High
$16.94
$11.66

Technical Indicators

Market Signals
Indicator
DEI
VIR
Relative Strength Index (RSI) 53.87 36.75
Support Level $11.15 $8.40
Resistance Level $12.70 $10.33
Average True Range (ATR) 0.41 0.44
MACD -0.02 -0.13
Stochastic Oscillator 52.24 4.85

Price Performance

Historical Comparison
DEI
VIR

About DEI Douglas Emmett Inc.

Douglas Emmett Inc is an integrated, self-administered, and self-managed REIT. The group focuses on owning, acquiring, developing, and managing a substantial market share of office properties and multifamily communities in neighborhoods with supply constraints, high-end executive housing, and key lifestyle amenities. Its properties are located in the Beverly Hills, Brentwood, Burbank, Century City, Olympic Corridor, Santa Monica, Sherman Oaks/Encino, Warner Center/Woodland Hills and Westwood submarkets of Los Angeles County, California, and in Honolulu, Hawaii. It has two business segments: the office segment and multifamily segment, of which Office segment derives maximum revenue.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Share on Social Networks: